Toggle light / dark theme

A third path to explain consciousness: Biological computationalism

Right now, the debate about consciousness often feels frozen between two entrenched positions. On one side sits computational functionalism, which treats cognition as something you can fully explain in terms of abstract information processing: get the right functional organization (regardless of the material it runs on) and you get consciousness.

On the other hand is biological naturalism, which insists that consciousness is inseparable from the distinctive properties of living brains and bodies: biology isn’t just a vehicle for cognition, it is part of what cognition is. Each camp captures something important, but the stalemate suggests that something is missing from the picture.

In our new paper, we argue for a third path: biological computationalism. The idea is deliberately provocative but, we think, clarifying. Our core claim is that the traditional computational paradigm is broken or at least badly mismatched to how real brains operate.

High-resolution brain mapping using X-ray ptychography

“The brain is one of the most complex biological systems in the world,” says one of the senior authors. How neurons are wired together is what his group are trying to unravel – a field known as connectomics.

The author explains: “Take the liver: we know of about 40 cell types. We know how they are arranged. We know their functions. This is not true for the brain. And so, one could ask, what is the difference between the brain and the liver? If we look at a cell body in the brain and the liver, it’s not easy to distinguish the two. They both have a nucleus, an endoplasmic reticulum – they both have the same intercellular machinery, the same molecules, the same types of proteins. This is not the difference. What is really different is how the brain cells are organised and connected.”

Let’s talk numbers: in one cubic millimetre of brain tissue there are about 100 000 neurons, connected through about 700 million synapses and 4 kilometres of ‘cabling’

Abnormal protein activity found to promote cell migration and spread of glioblastoma

Ever wondered how the different cells in our body communicate with each other to fulfill their different roles-be it cells repairing a tissue injury or immune cells moving towards an invading pathogen (microorganisms that causes disease) to engulf it? To move forward or migrate, cells must exert forces or interact with their surrounding environment. Interestingly, however, a fault in these interactions can also be the reason for spread of deadly cancer cells, such as in glioblastoma or brain tumor. While the importance of these interactions is well-understood, the machinery involved in these interactions at the molecular level remains a mystery.

Now, a team of researchers led by Professor Naoyuki Inagaki from Nara Institute of Science and Technology, Japan, along with Dr. Yonehiro Kanemura from NHO Osaka National Hospital, Japan; Dr. Tatsuo Kinashi from Kansai Medical University, Japan; and Dr. Daisuke Kawauchi from Nagoya City University, Japan, has identified the underlying mechanism involving a protein called shootin1b that promotes cell migration or movement in glioblastoma. The study was published online in Advanced Science on August 13, 2025.

“We discovered that an abnormal activity of shootin1b promotes the movement of cancer cells and spread of glioblastoma, the most common and difficult to treat brain tumor in adults,” explains Professor Inagaki.

Ancient sea anemone sheds light on animal cell type evolution

One of the biggest quests in biology is understanding how every cell in an animal’s body carries an identical genome yet still gives rise to a kaleidoscope of different cell types and tissues. A neuron doesn’t look nor behave like a muscle cell but has the same DNA.

Researchers think it comes down to how cells allow different parts of the genome to be read. Controlling these permissions are regulatory elements, regions of the genome which switch genes on or off. A detailed overview of how they do this is largely restricted to a handful of classic model organisms like mice and fruit flies.

Homer1 gene calms the mind and improves attention in mice

Attention disorders such as ADHD involve a breakdown in our ability to separate signal from noise. The brain is constantly bombarded with information, and focus depends on its ability to filter out distractions and detect what matters.

Stimulant medications improve attention by boosting activity in circuits known to govern attention, such as the prefrontal cortex. But a new study reveals a surprising alternative: reduce background activity as a way of turning down extraneous noise.

In a paper published in Nature Neuroscience, researchers show that the Homer1 gene plays a critical role in shaping attention in just that way. Mice with lower levels of two specific versions of the gene enjoyed quieter brain activity and improved ability to focus.

Prevalence and Factors Associated With Atrial Fibrillation Among Young Patients With Ischemic Stroke

Stra8 links neuronal activity to inhibitory circuit protection in the adult mouse brain.


Huang et al. show that Stra8, a gene previously thought to be germline specific, is expressed in the adult mouse hippocampus in an activity-dependent manner. Stra8 protects neuronal integrity and cognition by regulating neuromodulator genes and preserving inhibitory circuit function.

How common is Alzheimer’s? Blood-test study holds surprises

A Nature analysis of a major Norwegian study challenges existing estimates of Alzheimer’s prevalence, finding that 25% of people aged 85–89 have dementia with Alzheimer’s pathology — far higher than previous 7–13% estimates — while preclinical Alzheimer’s in younger seniors (70−74) occurs at only 8% versus earlier 22% estimates. Using blood biomarker pTau217 in 11,486 participants, researchers identified that 10% of over-70s had dementia, 10% had mild cognitive impairment, and 10% had preclinical Alzheimer’s, but warn that blood tests alone are insufficient for widespread screening due to potential harm from false positives. The discrepancies highlight how previous studies may have been skewed by selection bias, while demonstrating that blood-based biomarkers require careful interpretation and comprehensive clinical assessment.


A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to risk.

Physical and Cognitive Activities and Trajectories of AD Neuroimaging BiomarkersLongitudinal Analysis in the Mayo Clinic Study of Aging

Background and ObjectivesEngagement in physical and cognitive activities is associated with a decreased risk of mild cognitive impairment (MCI) and dementia, but the association with Alzheimer disease (AD) neuroimaging biomarkers is less clear. We thus…

Non-Opioid “Pain Sponge” Therapy Stops Cartilage Loss and Eases Chronic Pain

A new stem cell–based therapy challenges traditional pain treatment by using pain-sensing neurons to reduce inflammation and protect joints. Newly released preclinical data describes an unconventional strategy for managing chronic pain while helping preserve joint tissue. The findings focus on SN

/* */